B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptid
BCAP31
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BCAP31 Produkte
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LASNEAFKKQ AESASEAAKK YMEENDQLKK GAAVDGGKLD VGNAEVKLEE
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- BCAP31 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
- Hintergrund
-
This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16.
Alias Symbols: CDM, DDCH, BAP31, 6C6-AG, DXS1357E
Protein Size: 246 - Gen-ID
- 10134
- NCBI Accession
- NM_001139441, NP_001132913
- UniProt
- P51572
-
Sie sind hier:
